Prediction of recurrent clostridium difficile infection using comprehensive electronic medical records in an integrated healthcare delivery system

Infection Control and Hospital Epidemiology

Volumn 38, Issue 10, 2017, Pages 1196-1203

  Escobar, Gabriel J ^a   Baker, Jennifer M ^b   Kipnis, Patricia ^a,c   Greene, John D ^a   Mast, T Christopher ^d   Gupta, Swati B ^d   Cossrow, Nicole ^d   Mehta, Vinay ^d   Liu, Vincent ^a,c   Dubberke, Erik R ^e  

^a DIVISION OF RESEARCH   (United States)

^b Research and Evaluation Unit   (United States)

^c KAISER PERMANENTE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; CREATININE; LACTIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACCESS TO INFORMATION; AGE; AGED; ARTERIAL PH; ARTICLE; BODY TEMPERATURE; CALIBRATION; CALIFORNIA; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COPS2 SCORE; CRITICALLY ILL PATIENT; DEPENDENT VARIABLE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY ASSESSMENT; ELECTRONIC MEDICAL RECORD; EXPLANATORY VARIABLE; FEMALE; FOLLOW UP; GASTROINTESTINAL SURGERY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMMUNE DEFICIENCY; INCIDENTAL FINDING; INFECTION RISK; INTEGRATED HEALTH CARE SYSTEM; INTENSIVE CARE UNIT; LABORATORY BASED ACUTE PHYSIOLOGY SCORE VERSION 2; LABORATORY TEST; LENGTH OF STAY; LEUKOCYTE COUNT; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PERSONAL EXPERIENCE; PREDICTIVE VALUE; PREDICTOR VARIABLE; RECURRENCE RISK; RECURRENT CLOSTRIDIUM DIFFICILE INFECTION; RECURRENT INFECTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UREA NITROGEN BLOOD LEVEL; VALIDATION STUDY; VITAL SIGN; CLOSTRIDIUM INFECTION; ELECTRONIC HEALTH RECORD; HEALTH MAINTENANCE ORGANIZATION; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CALIFORNIA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DELIVERY OF HEALTH CARE, INTEGRATED; ELECTRONIC HEALTH RECORDS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 85029857162     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.176     Document Type: Article

References (40)

1. Lessa FC, Winston LG, McDonald LC. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372: 2369-2370.
2. Kwon JH, Olsen MA, Dubberke ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am 2015;29:123-134.
3. Olsen MA, Young-Xu Y, Stwalley D, et al. The burden of Clostridium difficile infection: estimates of the incidence of CDI from US administrative databases. BMC Infect Dis 2016; 16:177.
4. Freedberg DE, Salmasian H, Cohen B, Abrams JA, Larson EL. Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed. JAMA Intern Med 2016;176:1801-1808.
5. McFarland LV. Renewed interest in a difficult disease: Clostridium difficile infections-epidemiology and current treatment strategies. Curr Opin Gastroenterol 2009;25:24-35.
6. Bouza E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect 2012;18 (Suppl 6):5-12.
7. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-1775.
8. Zilberberg MD, Reske K, Olsen M, Yan Y, Dubberke ER. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis 2014; 14:306.
9. Sheitoyan-Pesant C, Abou Chakra CN, Pepin J, Marcil-Heguy A, Nault V, Valiquette L. Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis 2016;62:574-580.
10. Hu MY, Katchar K, Kyne L, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009;136:1206-1214.
11. Eyre DW, Walker AS, Wyllie D, et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 2012;55:S77-S87.
12. Hebert C, Du H, Peterson LR, Robicsek A. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol 2013;34: 407-414.
13. D'Agostino RB Sr., Collins SH, Pencina KM, Kean Y, Gorbach S. Risk estimation for recurrent Clostridium difficile infection based on clinical factors. Clin Infect Dis 2014;58:1386-1393.
14. Kollef MH, Chen Y, Heard K, et al. A randomized trial of real-time automated clinical deterioration alerts sent to a rapid response team. J Hosp Med 2014;9:424-429.
15. Escobar GJ, Dellinger RP. Early detection, prevention, and mitigation of critical illness outside intensive care settings. J Hosp Med 2016;11:S5-S10.
16. Escobar GJ, Turk BJ, Ragins A, et al. Piloting electronic medical record-based early detection of inpatient deterioration in community hospitals. J Hosp Med 2016;11:S18-S24.
17. Watt M, Dinh A, Le Monnier A, Tilleul P. Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France. J Med Econ 2017;20: 678-686.
18. Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev 2017;3:CD004610.
19. Wilcox MH, Gerding DN, Poxton IR, et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Eng. J Med 2017;376:305-317.
20. Escobar GJ, Greene JD, Gardner MN, Marelich GP, Quick B, Kipnis P. Intra-hospital transfers to a higher level of care: contribution to total hospital and intensive care unit (ICU) mortality and length of stay (LOS). J Hosp Med 2011;6:74-80.
21. Liu V, Kipnis P, Rizk NW, Escobar GJ. Adverse outcomes associated with delayed intensive care unit transfers in an integrated healthcare system. J Hosp Med 2012;7:224-230.
22. Escobar GJ, Gardner MN, Greene JD, Draper D, Kipnis P. Riskadjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system. Med Care 2013;51:446-453.
23. Selby JV. Linking automated databases for research in managed care settings. Ann Intern Med 1997;127:719-724.
24. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
25. Zilberberg MD, Reske K, Olsen M, Yan Y, Dubberke ER. Development and validation of a recurrent Clostridium difficile risk-prediction model. J Hosp Med 2014;9:418-423.
26. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007;45: 1543-1549.
27. Dubberke ER, Yan Y, Reske KA, et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol 2011;32:360-366.
28. Hastie T, Tibshirani R, Friedman JH. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. 2nd ed. New York: Springer Verlag; 2009.
29. Allison PD. Logistic Regression Using SAS: Theory and Application. 2nd ed. Cary, NC: SAS Institute; 2012.
30. Hastie T, Tibshirani R, Friedman J, Franklin J. The elements of statistical learning: data mining, inference and prediction. Mathemat Intelligenc 2005;27:83-85.
31. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modelling of Time to Event Data. Hoboken, NJ: Wiley; 2008.
32. Cook DA, Duke G, Hart GK, Pilcher D, Mullany D. Review of the application of risk-adjusted charts to analyse mortality outcomes in critical care. Crit Care Resusc 2008;10:239-251.
33. Crowson CS, Atkinson EJ, Therneau TM. Assessing calibration of prognostic risk scores. Stat Method Med Res 2014;25:1692-1706.
34. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-935.
35. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-212.
36. Estrella A, Mishkin FS. Predicting US recessions: financial variables as leading indicators. Rev Econ Statist 1998;80:45-61.
37. McDonald EG, Milligan J, Frenette C, Lee TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile Infection. JAMA Intern Med 2015;175:784-791.
38. Deshpande A, Pasupuleti V, Thota P, et al. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2015;36:452-460.
39. Kuntz JL, Johnson ES, Raebel MA, et al. Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score. Clin Microbiol Infect 2015;21:256-262.
40. Kuntz JL, Smith DH, Petrik AF, et al. Predicting the risk of Clostridiumdifficile infection upon admission: a score to identify patients for antimicrobial stewardship efforts. Perm J 2016;20:20-25.